Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers

Molecular and Cellular Biochemistry

Volumn 278, Issue 1-2, 2005, Pages 203-212

  Santa María, Ismael ^a   Hernández, Félix ^a   Smith, Mark A ^b   Perry, George ^b   Avila, Jesús ^a   Moreno, Francisco J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Dopamine; Paired helical filaments; Quinones; Tau protein

Indexed keywords

1,4 BENZOQUINONE; DOPAMINE; HYDROQUINONE; POLYMER; QUINONE DERIVATIVE; TAU PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; MICROTUBULE ASSEMBLY; NERVE CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA; TAUOPATHY;

ANIMALS; BENZOQUINONES; BRAIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROQUINONES; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, IMMUNOELECTRON; NEUROBLASTOMA; POLYMERS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TAU PROTEINS; TUMOR CELLS, CULTURED;

EID: 26444569948     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-7499-6     Document Type: Article

References (45)

1. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913-4917, 1986 3088567
2. Goedert M: Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and alpha-synucleinopathies. Philos Trans R Soc Lond B Biol Sci 354: 1101-1118, 1999
3. Gamblin TC, Berry RW, Binder LI: Tau polymerization: Role of the amino terminus. Biochemistry 42: 2252-2257, 2003 10.1021/bi0272510
4. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA: Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383: 550-553, 1996 10.1038/383550a0
5. Perez M, Valpuesta JM, Medina M, Montejo de Garcini E, Avila J: Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction. J Neurochem 67: 1183-1190, 1996 8752125
6. Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E: RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 399: 344-349, 1996 10.1016/S0014-5793(96)01386-5
7. Gamblin TC, King ME, Kuret J, Berry RW, Binder LI: Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39: 14203-14210, 2000 10.1021/bi001876l
8. Perez M, Cuadros R, Smith MA, Perry G, Avila J: Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett 486: 270-274, 2000 10.1016/S0014-5793(00)02323-1
9. Wilson DM, Binder LI: Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150: 2181-2195, 1997 9176408
10. Ames BN: Mitochondrial decay, a major cause of aging, can be delayed. J Alzheimers Dis 6: 117-121, 2004 15096694
11. Mitchell P: The vital protonmotive role of coenzyme Q. In: Folkers K, Littarru GP, Yamamura T (eds). Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6, Elsevier, Amsterdam, 1991, pp 3-10
12. Larsen PL, Clarke CF: Extension of life-span in Caenorhabditis elegans by a diet lacking coenzyme Q. Science 295: 120-123, 2002 10.1126/ science.1064653
13. Tatar M, Rand DM: Aging. Dietary advice on Q. Science 295: 54-55, 2002
14. Santa-Maria I, Hernandez F, Martin CP, Avila J, Moreno FJ: Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 43: 2888-2897, 2004 10.1021/bi035345j
15. Smith MA, Sayre LM, Vitek MP, Monnier VM, Perry G: Early AGEing and Alzheimer's. Nature 374: 316, 1995
16. Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ: A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22: 3090-3099, 2002 11943812
17. Linert W, Jameson GN: Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's disease. J Inorg Biochem 79: 319-326, 2000 10.1016/S0162-0134(99)00238-X
18. Conway KA, Rochet JC, Bieganski RM, Lansbury PT, Jr: Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349, 2001 10.1126/ science.1063522
19. Pérez Martín C, Vázquez J, Avila J, Moreno FJ: P24, a glycogen synthase kinase 3 (GSK 3) inhibitor. Biochim Biophys Acta 1586: 113-122, 2002 11781156
20. Moreno FJ, Medina M, Perez M, Montejo de Garcini E, Avila J: Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin). FEBS Lett 372: 65-68, 1995 10.1016/0014-5793(95)00934-2
21. Medina M, Montejo de Garcini E, Avila J: The role of tau phosphorylation in transfected COS-1 cells. Mol Cell Biochem 148: 79-88, 1995 10.1007/ BF00929506
22. Goedert M, Jakes R: Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 9: 4225-4230, 1990 2124967
23. Moreno FJ, Avila J: Phosphorylation of stathmin modulates its function as a microtubule depolymerizing factor. Mol Cell Biochem 183: 201-209, 1998 10.1023/A:1006807814580
24. Crowther RA, Olesen OF, Smith MJ, Jakes R, Goedert M: Assembly of Alzheimer-like filaments from full-length tau protein. FEBS Lett 337: 135-138, 1994 10.1016/0014-5793(94)80260-2
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970 5432063
26. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J: Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20: 27-39, 2001 10.1093/emboj/20.1.27
27. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM: Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci USA 88: 5837-5841, 1991 1712107
28. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757, 1978 29704
29. Greenberg SG, Davies P: A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 87: 5827-5831, 1990 2116006
30. Zecca L, Zucca FA, Wilms H, Sulzer D: Neuromelanin of the substantia nigra: A neuronal black hole with protective and toxic characteristics. Trends Neurosci 26: 578-580, 2003 10.1016/j.tins.2003.08.009
31. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC: Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 95: 13103-13107, 1998 10.1073/pnas.95.22.13103
32. Avila J, Lucas JJ, Perez M, Hernandez F: Role of tau protein in both physiological and pathological conditions. Physiol Rev 84: 361-384, 2004 10.1152/physrev.00024.2003
33. Garcia-Perez J, Avila J, Diaz-Nido J: Implication of cyclin-dependent kinases and glycogen synthase kinase 3 in the phosphorylation of microtubule-associated protein 1B in developing neuronal cells. J Neurosci Res 52: 445-452, 1998 10.1002/ (SICI)1097-4547(19980515)52:4<445::AID-JNR8>3.0.CO;2-9
34. Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, Trojanowski JQ: Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol (Berl) 104: 7-11, 2002 10.1007/ s00401-002-0563-3
35. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM: Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300: 636-640, 2003 10.1126/science.1082324
36. Galloway PG, Bergeron C, Perry G: The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease. Neurosci Lett 100: 6-10, 1989 2548130
37. Perez M, Valpuesta JM, de Garcini EM, Quintana C, Arrasate M, Lopez Carrascosa JL, Rabano A, Garcia de Yebenes J, Avila J: Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol 152: 1531-1539, 1998 9626057
38. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA: Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767, 2001 11487050
39. Raina AK, Templeton DJ, Deak JC, Perry G, Smith MA: Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep 4: 23-27, 1999 10.1179/135100099101534701
40. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R: A C. elegans mutant that lives twice as long as wild type. Nature 366 461-464, 1993
41. Dillin A, Crawford DK, Kenyon C: Timing requirements for insulin/IGF-1 signaling in C. elegans. Science 298: 830-834, 2002 10.1126/ science.1074240
42. Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals. Science 299: 1346-1351, 2003 10.1126/ science.1081447
43. Longo VD, Fabrizio P: Regulation of longevity and stress resistance: A molecular strategy conserved from yeast to humans? Cell Mol Life Sci 59: 903-908, 2002 10.1007/s00018-002-8477-8
44. Boirie Y: Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle. Trends Endocrinol Metab 14: 393-394, 2003 10.1016/j.tem.2003.09.002
45. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA: Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023, 2001 11312286